Biomarkers for Oncology
JH · Effective Oct 1, 2015
155 active Medicare policies list C34.92, and 21 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 155
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
21 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 19 · All Aetna policies
| Policy | Effective | Status of C34.92 |
|---|---|---|
| Bevacizumab for Non-Ocular Indications | Feb 20, 2024 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Exhaled Breath Tests | Sep 15, 2023 | Covered |
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction |
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
J15 · Effective May 13, 2019
JE · Effective Jun 3, 2019
JF · Effective Jun 3, 2019
JJ · Effective Apr 8, 2019
JM · Effective Apr 8, 2019
J5 · Effective Apr 15, 2019
J8 · Effective Apr 15, 2019
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J5 · Effective Mar 15, 2020
J8 · Effective Mar 15, 2020
J15 · Effective Jul 27, 2020
JE · Effective Aug 24, 2020
JF · Effective Aug 24, 2020
JJ · Effective Jun 14, 2020
JM · Effective Jun 14, 2020
J5 · Effective Jun 14, 2020
J8 · Effective Jun 14, 2020
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
J15 · Effective Oct 24, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
J6 · Effective Apr 1, 2026
J6 · Effective Jul 1, 2026
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Jul 1, 2026
National · Effective Mar 5, 2026
| Jun 5, 2023 |
| Covered |
| Hyperthermia in Cancer Therapy | Feb 9, 2024 | Covered |
|---|
| In Vivo Analysis of Gastro-Intestinal and Urothelial Lesions | Oct 17, 2023 | Covered |
|---|
| Lung Cancer Screening | Jun 21, 2023 | Covered |
|---|
| Lung Imaging: Selected Techniques | Nov 10, 2023 | Covered |
|---|
| Policy | Effective | Status of C34.92 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |
| Policy | Effective | Status of C34.92 |
|---|---|---|
| Low-Level Laser and High-Power Laser Therapy | Mar 15, 2026 | Covered |